SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148330

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148330

Healthcare Smell Diagnostics Market, By Technology, By Sample Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Healthcare Smell Diagnostics Market is estimated to be valued at USD 286.4 Mn in 2026 and is expected to reach USD 654.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 286.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.50% 2033 Value Projection: USD 654.7 Mn

The global healthcare smell diagnostics market is an emerging diagnostic field that analyzes volatile organic compounds (VOCs) emitted by the human body that are associated with diseases. Technologies such as electronic nose, GC-MS, sensor-based VOC analysis and AI-enabled platforms are being explored for detection of diseases like cancer, respiratory diseases, metabolic disorders, neurological diseases and infections.

The global healthcare smell diagnostics market is gaining attention as healthcare systems are moving toward non-invasive, early and personalized diagnostics. Advances in sensor technology, AI and VOC profiling are enhancing the ability to detect disease-specific molecular patterns in support of the development of rapid breath- and biofluid-based diagnostic approaches.

Market Dynamics

The global healthcare smell diagnostics market is driven by the increasing incidence of disease diagnosis through non-invasive and early diagnosis, especially for respiratory, metabolic, neurological, infectious and cancerous diseases. The integration of artificial intelligence and machine learning along with electronic nose and volatile organic compound analysis platforms is expected to improve pattern recognition and diagnostic accuracy with real-time analysis. The increasing interest for portable and point of care diagnostics is expected to further propel the adoption of healthcare smell diagnostics.

However, the growth of healthcare smell diagnostics market is limited by factors such as absence of regulatory standardization, lack of reproducibility in VOC measurements, high cost of technology, and lack of clinical validation for many applications. Nevertheless, significant opportunities exist in the development of novel diagnostic applications, AI-based platforms, strategic collaborations, and increasing adoption of advanced diagnostics in Asia Pacific, Latin America, and the Middle East.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global healthcare smell diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Owlstone Medical Limited, Breathomix B.V., Breath Diagnostics, Inc., eNose Company B.V., Ainos, Inc., The eNose Company, Mistral S.r.l., Nanose Medical Ltd., AIREX Inc., and Ancon Medical Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global healthcare smell diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare smell diagnostics market

Market Segmentation

  • Technology Insights (Revenue, USD Mn, 2021 - 2033)
    • Electronic Nose (E-Nose)
    • Gas Chromatography-Mass Spectrometry (GC-MS)
    • Sensor-Based VOC Analysis
    • Mass Spectrometry-Based Analysis
    • Others
  • Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
    • Exhaled Breath
    • Blood
    • Urine
    • Saliva
    • Others
  • Application Insights (Revenue, USD Mn, 2021 - 2033)
    • Cancer Detection
    • Respiratory Disease Detection
    • Infectious Disease Detection
    • Metabolic Disease Detection
    • Gastrointestinal and Liver Disease Detection
    • Neurological Disease Detection
    • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Owlstone Medical Limited
    • Breathomix B.V.
    • Breath Diagnostics, Inc.
    • eNose Company B.V.
    • Ainos, Inc.
    • The eNose Company
    • Mistral S.r.l.
    • Nanose Medical Ltd.
    • AIREX Inc.
    • Ancon Medical Limited
Product Code: CMI10174

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Healthcare Smell Diagnostics Market, By Technology
    • Global Healthcare Smell Diagnostics Market, By Sample Type
    • Global Healthcare Smell Diagnostics Market, By Application
    • Global Healthcare Smell Diagnostics Market, By End User
    • Global Healthcare Smell Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Technology Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Industry Trends

4. Global Healthcare Smell Diagnostics Market, By Technology, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Electronic Nose (E-Nose)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Gas Chromatography-Mass Spectrometry (GC-MS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Sensor-Based VOC Analysis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Mass Spectrometry-Based Analysis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Healthcare Smell Diagnostics Market, By Sample Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Exhaled Breath
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Blood
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Urine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Saliva
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Healthcare Smell Diagnostics Market, By Application, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cancer Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Respiratory Disease Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Infectious Disease Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Metabolic Disease Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Gastrointestinal and Liver Disease Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Neurological Disease Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Healthcare Smell Diagnostics Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Healthcare Smell Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Owlstone Medical Limited
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Breathomix B.V.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Breath Diagnostics, Inc.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • eNose Company B.V.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ainos, Inc.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • The eNose Company
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mistral S.r.l.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanose Medical Ltd.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AIREX Inc.
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ancon Medical Limited
    • Company Highlights
    • Technology Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!